Institution: | (1) Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, 620-1081, Burrard Street, Vancouver, BC V6Z 1Y6, Canada;(2) School of Population and Public Health, University of British Columbia, 5804, Fairview Avenue, Vancouver, BC V6T 1Z3, Canada;(3) Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht and Caphri Research Institute, 6229, P Debyelaan 25, HX Maastricht, BC V6T 1Z3, The Netherlands;(4) Department of Rheumatology, St Albans City Hospital, 6229, Waverley Road, St Albans, Herts, AL3 5PN, UK;(5) Inflammation Market Access, Pfizer, Inc, 6229, 500 Arcola Road, Dock E-4303, Collegeville, PA 19426, USA |